Blog
03-12-2025Cross-posted from: NIAID Newsroom The antiviral drug tecovirimat used without other antivirals did not reduce...
NIAID Newsroom
Tecovirimat Is Safe but Ineffective as Treatment for Clade II Mpox - Blog
NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain 12-16-2024Cross-posted from: NIAID Newsroom The antiviral drug tecovirimat did not reduce the time to lesion resolution... - Blog
Kidney Transplantation Between Donors and Recipients with HIV Is Safe 10-17-2024Cross-posted from: NIAID Newsroom Kidney transplantation from deceased donors with HIV (HIV D+) to recipients... - Blog
Exploratory Analysis Associates HIV Drug Abacavir with Elevated Cardiovascular Disease Risk in Large Global Trial 07-26-2024Cross-posted from: NIAID Newsroom Transmission electron micrograph of HIV-1 virus particles (teal) budding and... - Blog
Statement: Long-Acting HIV Treatment Demonstrates Efficacy in People with Challenges Taking Daily Medicine as Prescribed 02-22-2024Cross-posted from: NIAID Newsroom Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine... - Blog
NIH Research Identifies Opportunities to Improve Future HIV Vaccine Candidates 12-20-2023Cross-posted from: NIAID Newsroom An effective HIV vaccine may need to prompt strong responses from immune... - Blog
Clinical Trial of HIV Vaccine Begins in United States and South Africa 09-26-2023Cross-posted from: NIAID newsroom Transmission electron micrograph of HIV-1 virus particles from infected H9 c... - Blog
Daily Statin Reduces the Risk of Cardiovascular Disease in People Living with HIV, Large NIH Study Finds 04-14-2023Cross-posted from NIAID Newsroom A National Institutes of Health (NIH) clinical trial was stopped early because... - Blog
Early HIV Diagnosis and Treatment Important for Better Long-term Health Outcomes 11-02-2022Cross-posted from NIAID Newsroom Antiretroviral drugs to treat HIV infection Credit: NIAID Starting antiretro... - Blog
Clinical Trial Evaluating Monkeypox Vaccine Begins 09-09-2022Cross-posted from NIAID Newsroom NIH Trial is Evaluating Intradermal Delivery to Expand the Vaccine Supply.... - Blog
Combination Anti-HIV Antibody Infusions Suppress Virus for Sustained Period 06-02-2022Cross-posted from NIAID Newsroom Strategy May Offer Alternative to Daily Antiretrovirals Individuals with HIV... - Blog
NIH Launches Clinical Trial of Three mRNA HIV Vaccines 03-23-2022 - Blog
Researchers Document Third Known Case of HIV Remission Involving Stem Cell Transplant 02-15-2022 - Blog
Experimental mRNA HIV Vaccine Safe, Shows Promise in Animals 12-15-2021 - Blog
Too Many People with HIV Fail to Achieve Durable Viral Suppression 11-30-2021 - Blog
NIH Experts Call for Accelerated Research to Address Concurrent HIV and COVID-19 Pandemics 04-09-2021 - Blog
NIH Announces Restructured HIV Clinical Trials Networks 12-03-2020 - Blog
NIAID Observes HIV Vaccine Awareness Day 2020 05-18-2020 - Blog
NIH-Funded AIDS Clinical Trials Group Conducts COVID-19 Treatment Study 05-15-2020 - Blog
NIH Study Finds Lower Concentration of PrEP Drug in Pregnant Young Women 03-09-2020